Disparities in HIV treatment and physician attitudes about delaying protease inhibitors for nonadherent patients
about
Training HIV physicians to prescribe buprenorphine for opioid dependence.Patients' perspectives on informal caregiver involvement in HIV health care appointments.Gender disparities in HIV health care utilization among the severely disadvantaged: can we determine the reasons?The interplay of sociodemographic factors on virologic suppression among a U.S. outpatient HIV clinic populationHIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited CohortsNo variability across centers in adherence and response to HAART in French hospitals: results from the ANRS-EN12-VESPA study.A randomized controlled trial of Structural Ecosystems Therapy for HIV medication adherence and substance abuse relapse prevention.Disparities in CD4+ T-Lymphocyte Monitoring Among Human Immunodeficiency Virus-Positive Medicaid Beneficiaries: Evidence of Differential Treatment at the Point of Care.Does racial concordance between HIV-positive patients and their physicians affect the time to receipt of protease inhibitors?The Demand for Antiretroviral Drugs in the Illicit Marketplace: Implications for HIV Disease Management Among Vulnerable PopulationsDisparity in physician perception of patients' adherence to medications by obesity statusTrauma healthcare providers' knowledge of alcohol abuse.Clinician Perspectives on Delaying Initiation of Antiretroviral Therapy for Clinically Eligible HIV-Infected Patients.HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: a survey of North American HIV providers.Effect of HIV Housing Services on Engagement in Care and Treatment, New York City, 2011.HIV providers' perceptions of and attitudes toward female versus male patientsHIV Medication Adherence and Substance Use: The Smartest Women's Project.Medical Students' Attitudes Toward Non-Adherent Patients Before and After a Simulated Patient-Role Activity and Small-Group Discussion: Revisited.A pilot study to engage and counsel HIV-positive African American youth via telehealth technology.Racial, gender and geographic disparities of antiretroviral treatment among US Medicaid enrolees in 1998Adapting effective narrative-based HIV-prevention interventions to increase minorities' engagement in HIV/AIDS services.Race, place and AIDS: the role of socioeconomic context on racial disparities in treatment and survival in San Francisco.Factors Related to HIV testing among an African American church-affiliated population.Sticking to it: the effect of maximally assisted therapy on antiretroviral treatment adherence among individuals living with HIV who are unstably housed.Comparison of AUDIT-C collected via electronic medical record and self-administered research survey in HIV infected and uninfected patients.Patient profiles as organizing HIV clinicians' ART adherence management: a qualitative analysis.Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders.Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression.Factors associated with adherence to highly active antiretroviral therapy in homeless or unstably housed adults living with HIV.Health status, health care use, medication use, and medication adherence among homeless and housed people living with HIV/AIDS.Antiretroviral therapy: a key part of the public health response to injection drug use.Community poverty and trends in racial/ethnic survival disparities among people diagnosed with AIDS in Florida, 1993-2004
P2860
Q30230238-D57AC095-FA99-49C3-8CA3-131476A29944Q33705650-06748A08-1A66-491E-A32E-1850D99BB16EQ33810823-E26EA4AA-2513-48A3-9D8A-9613639162D4Q33827836-9B5F322E-C140-4866-B172-02497B873D49Q33907350-01D44116-4FF9-4D58-A4B9-BB030A52D70FQ34115350-1CF0738A-B091-42E2-B008-2946C04A9CB0Q34176604-1B5F3F4C-0C19-4F78-B8A1-F296856847AEQ34508737-BA2EE9C0-71A5-4C4A-99DB-57FB8F65A20BQ34740792-F4C0D090-A06B-43AD-943B-07567D1BD2DDQ35054628-9A704CA3-5177-4589-B437-5605EDDCD789Q35146396-4974102B-0EA3-4EDC-9994-604954D873BAQ35152122-780A2867-CC48-4B76-B666-BEF5B2A4B12EQ35589224-5B5058F4-49C8-477D-A63E-3C0878BB8022Q35686969-4539CAFB-2377-4A59-91C8-AA67B19053C3Q35835854-262E26A2-1864-4E4A-9A76-1A67B8133B0DQ36137776-946C1A13-1CE1-464B-82A9-E875FCD7ED1DQ36291793-1E394037-671B-4B2A-91D4-9570FBB265DDQ36798814-468244EE-80DC-49FD-BA0A-6A1345757F5CQ36917683-6FA62963-4E38-4AAC-B86A-51629A0F721FQ37139600-0E95D4ED-BBDE-4D80-BB99-55A354971AB3Q37300493-34C4E5CC-7459-4F3F-A756-5D5481545E04Q37353128-B1B6C9B9-0BF8-4675-BBCF-1E2F2141B318Q37393197-8B885CBC-13FC-4731-B1B7-2F67CF62C8B4Q37616586-D655D951-9443-48C2-B3C7-5D085DEF89E6Q37624380-940F3463-DE4E-4C2F-8AD0-AEFA8958B002Q39331220-0FC01D1B-9895-468B-98BE-128D6801281FQ40099256-ADD11CE8-303E-4682-A40E-7789ED7B2A00Q41616426-D9110377-CADE-4CC9-9A9A-65A57BEF47D2Q46474715-CC4A78EB-3C98-46EA-AF6C-C772FC5A386FQ50104958-7831A2C5-F9D3-47E9-8FB5-A1AE5BB06B22Q51897843-ABD2FD59-B603-4A53-A5F6-2441AC70B3E7Q52292656-F04F0DE1-D6BE-4930-972B-36CA87546629Q58856106-DF468E51-1D42-4D32-84A6-77503427BD74
P2860
Disparities in HIV treatment and physician attitudes about delaying protease inhibitors for nonadherent patients
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Disparities in HIV treatment a ...... itors for nonadherent patients
@ast
Disparities in HIV treatment a ...... itors for nonadherent patients
@en
Disparities in HIV treatment a ...... itors for nonadherent patients
@nl
type
label
Disparities in HIV treatment a ...... itors for nonadherent patients
@ast
Disparities in HIV treatment a ...... itors for nonadherent patients
@en
Disparities in HIV treatment a ...... itors for nonadherent patients
@nl
prefLabel
Disparities in HIV treatment a ...... itors for nonadherent patients
@ast
Disparities in HIV treatment a ...... itors for nonadherent patients
@en
Disparities in HIV treatment a ...... itors for nonadherent patients
@nl
P2093
P2860
P1476
Disparities in HIV treatment a ...... itors for nonadherent patients
@en
P2093
Bruce E Landon
HCSUS Consortium
Hong Hu Liu
Martin F Shapiro
Naihua Duan
Neil S Wenger
Paul D Cleary
Ronald M Andersen
William E Cunningham
P2860
P304
P356
10.1111/J.1525-1497.2004.30429.X
P577
2004-04-01T00:00:00Z
P5875
P6179
1001876662